Innophos — Merger or Acquisition (August 2017)
22 slides from Innophos's merger presentation, Aug 1, 2017
Slide 1: Revitalized for Growth: Novel Ingredients Acquisition
REVITALIZED FOR GROWTH NOVEL INGREDIENTS ACQUISITION August 1, 2017 – 9:00 am ET Exhibit 99.2
Slide 2: Forward-Looking Statements
Forward-Looking Statements This presentation contains or may contain forward-looking statements within the meaning of Section 27a of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The company intends these forward-looking statements to be
Slide 3: Agenda
Kim Ann Mink, Ph.D. Chairman, President and Chief Executive Officer Han Kieftenbeld SVP and Chief Financial Officer Agenda Novel Ingredients Acquisition Q&A Novel Ingredients Acquisition | August 1, 2017
Slide 4: Novel Brings Growth And Complementary Capabilities
Novel Brings Growth And Complementary Capabilities Innophos announces definitive agreement to acquire Novel Ingredients + Creates nearly $0.5 billion Food, Health and Nutrition (FHN) platform; 60% of total Company sales Advances Vision 2022 growth strategy and enhances innovation Expands Innophos’ o
Slide 5: Novel Is A Strong Fit With Our Purpose
VITAL INGREDIENTS Novel Is A Strong Fit With Our Purpose To provide vital ingredients for the nutrition and health of those around us, leveraging science and technology in partnership with our customers and informed by consumer trends, with a view to create value for our stakeholders. “ ” Food Healt
Slide 6: Novel Advances Our Vision 2022 On All Strategic Aspects
A leading specialty ingredients solutions provider to Food, Health and Nutrition end-markets Selective added value player in industrial specialties applications Best-in-class practices, agile supply chain and cost effective operations Aligned with consumer trends and partner of choice through vital
Slide 7: Creates A Nearly $0.5 Billion Food, Health and Nutrition Platform
Creates A Nearly $0.5 Billion Food, Health and Nutrition Platform; 60% of Total Company Sales + Note: Revenue split based on estimated pro forma revenues for 2017 Food, Health and Nutrition Industrial Specialties Other Ingredients Blends/Formulations Branded Other Food, Health and Nutrition Industri
Slide 8: Novel, A Technology Driven Specialty Ingredients Solution Provider
Novel, A Technology Driven Specialty Ingredients Solution Provider High growth end-markets Complementary combination Strong financial transaction rationale Prudently financed Annual revenue of nearly $100 million; 2008-2016 CAGR of 19%. Headquartered in NJ, USA Serving attractive end-markets driven
Slide 9: Novel Brings A Strong Set of Capabilities
Novel Brings A Strong Set of Capabilities High growth end-markets Complementary combination Strong financial transaction rationale Prudently financed Novel, an attractive business Manufacturing Development Sourcing Processing Quality Assurance & Certification Processes including blending, granulatio
Slide 10: More Closely Aligned With Consumer Megatrends
More Closely Aligned With Consumer Megatrends High growth end-markets Complementary combination Strong financial transaction rationale Prudently financed Novel, an attractive business Health and Wellness Energized Ageing Convenience and Time Effectiveness Protection and Preservation Clean Label/Gree
Slide 11: End-Markets With Demonstrated Growth In 4-8% Range
End-Markets With Demonstrated Growth In 4-8% Range High growth end-markets Complementary combination Strong financial transaction rationale Prudently financed Novel, an attractive business Rising demand for products with specific health benefits and natural characteristics Changing consumer patterns
Slide 12: Strengthened Foothold In $7.2bn NA Nutraceutical Market
Strengthened Foothold In $7.2bn NA Nutraceutical Market High growth end-markets Complementary combination Strong financial transaction rationale Prudently financed Novel, an attractive business SOURCE: Markets & Markets, 2016 Application 2015 NAM Market Size* 2015-2020 NAM CAGR Dietary Supplements 2
Slide 13: Complementary Market And Product Coverage
Complementary Market And Product Coverage High growth end-markets Complementary combination Strong financial transaction rationale Prudently financed Novel, an attractive business Global Supplement Companies Mid-tier Supplement Companies Global Food Companies Market Coverage Botanicals Minerals Exci
Slide 14: Attractive And Highly Complementary Product Portfolios
Attractive And Highly Complementary Product Portfolios High growth end-markets Complementary combination Strong financial transaction rationale Prudently financed Novel, an attractive business Immune Health Heart Health Sports Nutrition & Energy Antioxidants & Specialty Botanicals Protein & Amino Ac
Slide 15: Novel Brings Strong Portfolio Of Branded Products
Novel Brings Strong Portfolio Of Branded Products High growth end-markets Complementary combination Strong financial transaction rationale Prudently financed Novel, an attractive business Kinetiq™ Cera-Q™ Acumin™ QU995™ PhysiCor™ A next-gen, natural citrus aurantium extract clinically demonstrated t
Slide 16: Sharing A Strong And Diverse Customer Base
Sharing A Strong And Diverse Customer Base High growth end-markets Complementary combination Strong financial transaction rationale Prudently financed Novel, an attractive business Opportunity to leverage combined portfolio and grow customer base Innophos has longstanding relationships with market l
Slide 17: Supports Our Commitment To Grow And Diversify Earnings
Supports Our Commitment To Grow And Diversify Earnings High growth end-markets Complementary combination Prudently financed Novel, an attractive business Strong financial transaction rationale Adds ~$100 million of annual revenue Accretive to earnings per share within the first year of combined oper
Slide 18: Leveraging Our Cost Effective Existing Credit Facility
Leveraging Our Cost Effective Existing Credit Facility High growth end-markets Complementary combination Novel, an attractive business All-cash consideration of $125 million Acquisition will be funded with borrowings under current cost effective credit facility Net leverage to increase from 1.2x to
Slide 19: Novel is Strategically and Financially A Strong Fit
Novel is Strategically and Financially A Strong Fit STRATEGIC FITFINANCIAL FIT Expanded solution capability to better serve our customers Diversifies participation in higher growth Food, Health and Nutrition segments Recognized as a leader in markets served Provides revenue synergies from customer p
Slide 20: A Winning Combination
A Winning Combination STRATEGIC FIT Overlapping customers and sales channels Linked to consumer trends Technology enabled MORE GROWTH Leadership in markets served Expands aperture for profitable and faster growth FAVORABLE ECONOMICS Value > investment Enhanced earnings profile Sustainable cash flow
Slide 21: Q2 2017 Earnings Call and Novel Ingredients Acquisition Q&A
Q2 2017 EARNINGS CALL and NOVEL INGREDIENTS ACQUISITION August 1, 2017 – 9:00 am ET Q&A
Slide 22: About the Company
ABOUT THE COMPANY Innophos (NASDAQ: IPHS) is a leading international producer of specialty ingredient solutions that deliver far-reaching, versatile benefits for the food, health, nutrition and industrial markets. We leverage our expertise in the science and technology of blending and formulating ph
Innophos Holdings — Merger or Acquisition (August 2017) on 6ix